These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

802 related items for PubMed ID: 12756819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M, Thomsen MK.
    Ugeskr Laeger; 2003 Apr 14; 165(16):1649-52. PubMed ID: 12756820
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G.
    Eur J Clin Pharmacol; 2002 Nov 14; 58(8):495-500. PubMed ID: 12451425
    [Abstract] [Full Text] [Related]

  • 5. [European Agency for the Evaluation of Medicinal Products: five years experience].
    Sauer F.
    Bull Mem Acad R Med Belg; 2000 Nov 14; 155(5-6):254-8; discussion 259-62. PubMed ID: 11304960
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
    Bottomley A, Jones D, Claassens L.
    Eur J Cancer; 2009 Feb 14; 45(3):347-53. PubMed ID: 19013787
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Europe and medicines: role of the EMEA].
    Sauer F.
    Ann Pharm Fr; 2000 Jul 14; 58(4):278-85. PubMed ID: 10915977
    [Abstract] [Full Text] [Related]

  • 12. [European network for investigation of medicinal products in children (Medichildren)].
    Pons G.
    Arch Pediatr; 2006 Jun 14; 13(6):631. PubMed ID: 16713209
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [National and European drug approval procedures].
    Mohrbutter KP.
    Z Arztl Fortbild Qualitatssich; 1997 Nov 14; 91(7):593-6. PubMed ID: 9527447
    [Abstract] [Full Text] [Related]

  • 15. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Jan 04; 67(3):602-3. PubMed ID: 12358039
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe.
    Boon WP, Moors EH, Meijer A, Schellekens H.
    Clin Pharmacol Ther; 2010 Dec 04; 88(6):848-53. PubMed ID: 20962774
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan 04; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 20. Drug evaluation and approval process in the European Union.
    San Miguel MT, Vargas E.
    Arthritis Rheum; 2006 Feb 15; 55(1):12-4. PubMed ID: 16463405
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.